Tag archive for ‘Cell therapy’
Zami Aberman Pluristem

Pluristem’s Study Results Showing Improved Bone Marrow Transplantation

Pluristem Therapeutics Inc.(Nasdaq:PSTI; DAX: PJT: PLTR;TASE:PSTI), a developer of placenta-based cell therapy products, announced today strong positive data from a preclinical study of PLX-R18 cells to More...

Zami Aberman Pluristem

Pluristem’s Phase I/II Muscle Injury Trial Successfully Meets Primary Safety & Efficacy Endpoints

Pluristem Therapeutics Inc. (NasdaqCM: PSTI; TASE: PLTR), a leading developer of placenta-based cell therapies, today announced top-line results from its Phase I/II clinical trial testing the safety More...

Wordpress site Developed by Fixing WordPress Problems